You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Islet culture, shipping, and infusion device

    SBC: WILSON WOLF MANUFACTURING CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): The culture and shipment of islets are an integral part of islet transplant research. Flasks, petri dishes, and bags are the devices used to perform that role. However, these devices have inherent design characteristics that make them poorly suited to the unique needs of islet culture and islet shipping. This results in the use of far too many devices to maint ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  2. Minimally Invasive Cardiac Monitor for Neonatal and Pediatric ICU

    SBC: TRANSONIC SYSTEMS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Currently there exists no technology for routine measurement of cardiac output (CO) in neonates (0.4-2.5Kg) and low weight pediatric (2.5Kg+) patients in the intensive care unit (ICU). Accurate measurement of CO would a llow for better assessment of therapies and thereby improve patient health care. Conventional methods used with adults for routine CO measureme ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  3. Novel PDE Inhibitors for Treatment of Cognitive Dysfunction in Schizophrenia

    SBC: INTRA-CELLULAR THERAPIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): This proposal is submitted as a Phase II SBIR application, pursuant to our existing Phase I grant, which was funded in response to the NIMH Program Announcement #PA-02-027 entitled: "Pharmacological agents and drugs for mental disorders". The development of new pharmaceuticals for neuropsychiatric disorders is limited by the lack of rapid and effective methods ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  4. Refanalin for lung preservation and transplantation

    SBC: Angion Biomedica Corp.            Topic: N/A

    DESCRIPTION (provided by applicant): Lung transplantation is the only effective treatment modality for patients with end-stage lung disease. Ischemia-reperfusion injury, associated with the retrieval, storage and transplantation of the lung is a major immu ne-independent factor adversely affecting early graft function, graft viability and recipient morbidity and mortality. Marginal donor lungs, ar ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  5. Educational Television Program for Children of Immigrant Families

    SBC: Transcendent International, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): The language barrier between immigrant parents and their English-dominant children is a pervasive and relatively unrecognized problem in an estimated 12 million U.S. households. This intergenerational language gap often leads to adverse health outcomes for both children and adults for the following reasons: (1) it hinders young children's ability to communicat ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  6. Impedance Threshold Value for Improving Standard CPR

    SBC: ADVANCED CIRCULATORY SYSTEMS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Despite the widespread practice of basic and advanced life support, over 1000 patients die each day in the United States from an out-of-hospital cardiac arrest. Even though they receive standard cardiopulmonary resuscitation (sCPR) the average national survival to hospital discharge for these patients is less than 5%. The applicants have developed the inspir ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  7. Development of a Digital Sign System for Indoor Wayfinding by the Visually Impair

    SBC: ADVANCED MEDICAL ELECTRONICS CORP            Topic: N/A

    DESCRIPTION (provided by applicant): It is challenging for visually-impaired people to find their way in unfamiliar, complex indoor spaces such as schools or office buildings. GPS technology has already been exploited for speech-based navigation for visual ly-impaired wayfinding in outdoor environments, but there is no equivalent technology for indoor wayfinding. Sighted pedestrians may sometimes ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  8. Novel Nitrogen Enriched Air for Fire Suppression

    SBC: COMPACT MEMBRANE SYSTEMS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The objective of this Compact Membrane Systems (CMS) program is to develop a new platform technology for fire suppression and fire prevention systems around membrane supplied nitrogen enriched air (NEA). The limitation that the atmospheres used in the fire suppression be breathable to occupants in the proximity of a fire is easily accomplished by CMS technolog ...

    SBIR Phase II 2008 Department of Health and Human ServicesCenters for Disease Control and Prevention
  9. High Throughput in Vivo Drug Discovery- Phase II

    SBC: PGI HOLDING CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): This Phase II application is being submitted in response to a continuing NIMH program announcement for Pharmacological Agents and Drugs for Mental Disorders. The goal of the proposal is to use an innovative behavior-dri ven approach to psychiatric drug discovery to overcome the major limitations associated with target-driven approaches that have impeded the dis ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  10. Treatment of Surgical Sepsis with AM/AMBP-1

    SBC: THERASOURCE, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): This SBIR Phase II proposal is a plan to further develop a new therapeutic approach that will save the lives of patients with sepsis (especially surgical sepsis), a condition that affects 750,000 people every year in th e United States alone and also causes high mortality worldwide. Although activated protein C [APC, Drotrecogin alpha (activated), Xigris. marke ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government